Carle Cancer Center is a clinical research site located in Urbana, Illinois, United States 61801.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Carle Cancer Center has participated in 532 clinical trials with 316 currently active.
Therapeutic areas: Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8.
Sponsors: SWOG Cancer Research Network, CTI BioPharma, GOG Foundation.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Carle Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Carle Cancer Center has 532 clinical trials on record, with 316 currently active. Their work covers Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8.
Carle Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.